103 related articles for article (PubMed ID: 23947435)
1. Navigating veterans with an abnormal prostate cancer screening test: a quasi-experimental study.
Simon MA; Nonzee NJ; McKoy JM; Liu D; Luu TH; Byer P; Eklund EA; Richey EA; Wu Z; Dong X; Rademaker AW
BMC Health Serv Res; 2013 Aug; 13():314. PubMed ID: 23947435
[TBL] [Abstract][Full Text] [Related]
2. Design of a prostate cancer patient navigation intervention for a Veterans Affairs hospital.
Nonzee NJ; McKoy JM; Rademaker AW; Byer P; Luu TH; Liu D; Richey EA; Samaras AT; Panucci G; Dong X; Simon MA
BMC Health Serv Res; 2012 Sep; 12():340. PubMed ID: 23009152
[TBL] [Abstract][Full Text] [Related]
3. Patient navigation improves cancer diagnostic resolution: an individually randomized clinical trial in an underserved population.
Raich PC; Whitley EM; Thorland W; Valverde P; Fairclough D;
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1629-38. PubMed ID: 23045537
[TBL] [Abstract][Full Text] [Related]
4. Impact of patient navigation on timely cancer care: the Patient Navigation Research Program.
Freund KM; Battaglia TA; Calhoun E; Darnell JS; Dudley DJ; Fiscella K; Hare ML; LaVerda N; Lee JH; Levine P; Murray DM; Patierno SR; Raich PC; Roetzheim RG; Simon M; Snyder FR; Warren-Mears V; Whitley EM; Winters P; Young GS; Paskett ED;
J Natl Cancer Inst; 2014 Jun; 106(6):dju115. PubMed ID: 24938303
[TBL] [Abstract][Full Text] [Related]
5. Follow-up and timeliness after an abnormal cancer screening among underserved, urban women in a patient navigation program.
Markossian TW; Darnell JS; Calhoun EA
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1691-700. PubMed ID: 23045544
[TBL] [Abstract][Full Text] [Related]
6. The impact of patient navigation on the delivery of diagnostic breast cancer care in the National Patient Navigation Research Program: a prospective meta-analysis.
Battaglia TA; Darnell JS; Ko N; Snyder F; Paskett ED; Wells KJ; Whitley EM; Griggs JJ; Karnad A; Young H; Warren-Mears V; Simon MA; Calhoun E
Breast Cancer Res Treat; 2016 Aug; 158(3):523-34. PubMed ID: 27432417
[TBL] [Abstract][Full Text] [Related]
7. Five-year downstream outcomes following prostate-specific antigen screening in older men.
Walter LC; Fung KZ; Kirby KA; Shi Y; Espaldon R; O'Brien S; Freedland SJ; Powell AA; Hoffman RM
JAMA Intern Med; 2013 May; 173(10):866-73. PubMed ID: 23588999
[TBL] [Abstract][Full Text] [Related]
8. Clinician Factors Associated With Prostate-Specific Antigen Screening in Older Veterans With Limited Life Expectancy.
Tang VL; Shi Y; Fung K; Tan J; Espaldon R; Sudore R; Wong ML; Walter LC
JAMA Intern Med; 2016 May; 176(5):654-61. PubMed ID: 27042937
[TBL] [Abstract][Full Text] [Related]
9. Boston Patient Navigation Research Program: the impact of navigation on time to diagnostic resolution after abnormal cancer screening.
Battaglia TA; Bak SM; Heeren T; Chen CA; Kalish R; Tringale S; Taylor JO; Lottero B; Egan AP; Thakrar N; Freund KM
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1645-54. PubMed ID: 23045539
[TBL] [Abstract][Full Text] [Related]
10. Relation of comorbidities and patient navigation with the time to diagnostic resolution after abnormal cancer screening.
Whitley EM; Raich PC; Dudley DJ; Freund KM; Paskett ED; Patierno SR; Simon M; Warren-Mears V; Snyder FR;
Cancer; 2017 Jan; 123(2):312-318. PubMed ID: 27648520
[TBL] [Abstract][Full Text] [Related]
11. Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: Data from the Patient Navigation Research Program.
Ramachandran A; Snyder FR; Katz ML; Darnell JS; Dudley DJ; Patierno SR; Sanders MR; Valverde PA; Simon MA; Warren-Mears V; Battaglia TA;
Cancer; 2015 Nov; 121(22):4016-24. PubMed ID: 26385420
[TBL] [Abstract][Full Text] [Related]
12. Low-Value Prostate Cancer Screening Among Older Men Within the Veterans Health Administration.
Radomski TR; Huang Y; Park SY; Sileanu FE; Thorpe CT; Thorpe JM; Fine MJ; Gellad WF
J Am Geriatr Soc; 2019 Sep; 67(9):1922-1927. PubMed ID: 31276198
[TBL] [Abstract][Full Text] [Related]
13. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.
Chamie K; DeVere White RW; Lee D; Ok JH; Ellison LM
Cancer; 2008 Nov; 113(9):2464-70. PubMed ID: 18666213
[TBL] [Abstract][Full Text] [Related]
14. Physician communication regarding prostate cancer screening: analysis of unannounced standardized patient visits.
Feng B; Srinivasan M; Hoffman JR; Rainwater JA; Griffin E; Dragojevic M; Day FC; Wilkes MS
Ann Fam Med; 2013; 11(4):315-23. PubMed ID: 23835817
[TBL] [Abstract][Full Text] [Related]
15. Patient Navigation for Comprehensive Cancer Screening in High-Risk Patients Using a Population-Based Health Information Technology System: A Randomized Clinical Trial.
Percac-Lima S; Ashburner JM; Zai AH; Chang Y; Oo SA; Guimaraes E; Atlas SJ
JAMA Intern Med; 2016 Jul; 176(7):930-7. PubMed ID: 27273602
[TBL] [Abstract][Full Text] [Related]
16. Can patient navigation improve receipt of recommended breast cancer care? Evidence from the National Patient Navigation Research Program.
Ko NY; Darnell JS; Calhoun E; Freund KM; Wells KJ; Shapiro CL; Dudley DJ; Patierno SR; Fiscella K; Raich P; Battaglia TA
J Clin Oncol; 2014 Sep; 32(25):2758-64. PubMed ID: 25071111
[TBL] [Abstract][Full Text] [Related]
17. Patient Navigation Improves Subsequent Breast Cancer Screening After a Noncancerous Result: Evidence from the Patient Navigation in Medically Underserved Areas Study.
Molina Y; Kim SJ; Berrios N; Glassgow AE; San Miguel Y; Darnell JS; Pauls H; Vijayasiri G; Warnecke RB; Calhoun EA
J Womens Health (Larchmt); 2018 Mar; 27(3):317-323. PubMed ID: 28933653
[TBL] [Abstract][Full Text] [Related]
18. Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer.
Sarkar RR; Parsons JK; Bryant AK; Ryan ST; Kader AK; McKay RR; D'Amico AV; Nguyen PL; Hulley BJ; Einck JP; Mundt AJ; Kane CJ; Murphy JD; Rose BS
JAMA Intern Med; 2019 Jun; 179(6):812-819. PubMed ID: 31058923
[TBL] [Abstract][Full Text] [Related]
19. Pairing physician education with patient activation to improve shared decisions in prostate cancer screening: a cluster randomized controlled trial.
Wilkes MS; Day FC; Srinivasan M; Griffin E; Tancredi DJ; Rainwater JA; Kravitz RL; Bell DS; Hoffman JR
Ann Fam Med; 2013; 11(4):324-34. PubMed ID: 23835818
[TBL] [Abstract][Full Text] [Related]
20. The Ohio Patient Navigation Research Program: does the American Cancer Society patient navigation model improve time to resolution in patients with abnormal screening tests?
Paskett ED; Katz ML; Post DM; Pennell ML; Young GS; Seiber EE; Harrop JP; DeGraffinreid CR; Tatum CM; Dean JA; Murray DM;
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1620-8. PubMed ID: 23045536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
